| Putting patients first in medicines regulation? H Naci, R Forrest, C Davis bmj 375, 2021 | 4 | 2021 |
| Prioritising patients in negotiations over drug pricing R Forrest, H Naci bmj 381, 2023 | 3 | 2023 |
| A Primer on Pharmaceutical Policy and Economics H Naci, R Forrest https://www.health.org.uk/sites/default/files/2023-03 …, 2023 | 2 | 2023 |
| Characteristics of Prior Authorization Policies for New Drugs in Medicare Part D H Naci, R Forrest, M Zhai, AR Stofesky, AS Kesselheim JAMA Health Forum 4 (2), e225610-e225610, 2023 | 2 | 2023 |
| Pharmaceutical Policy in the UK H Naci, R Forrest https://www.health.org.uk/sites/default/files/2023-03 …, 2023 | | 2023 |
| Design Principles for a Coherent Pharmaceutical System H Naci, R Forrest https://www.health.org.uk/sites/default/files/2023-03 …, 2023 | | 2023 |
| PMH40 Expansion of state Medicaid programs: increased patient access to opioid replacement therapy? S Atrah, C O'Leary, R Forrest, R Beale Value in Health 22, S232, 2019 | | 2019 |
